Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2016, Article ID 8402942, 4 pages
http://dx.doi.org/10.1155/2016/8402942
Case Report

Treatment of a Coronary Bifurcation Lesion Using One Dedicated Sirolimus Eluting Bifurcation Stent in Combination with a Bioresorbable Vascular Scaffold: A Novel Option for Coronary Bifurcation Approach

Department of Cardiology, Hospital de Jerez de la Frontera, Jerez de la Frontera, Ronda de Circunvalación s/n, 11407 Cádiz, Spain

Received 27 January 2016; Accepted 28 February 2016

Academic Editor: Man-Hong Jim

Copyright © 2016 Javier Benezet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Al Suwaidi, P. B. Berger, C. S. Rihal et al., “Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions,” Journal of the American College of Cardiology, vol. 35, no. 4, pp. 929–936, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. J. F. Lassen, N. R. Holm, G. Stankovic et al., “Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10 years of the European Bifurcation Club meetings,” EuroIntervention, vol. 10, no. 5, pp. 545–560, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Guérin, P. Pilet, G. Finet et al., “Drug-eluting stents in bifurcations: bench study of strut deformation and coating lesions,” Circulation: Cardiovascular Interventions, vol. 3, no. 2, pp. 120–126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Medina, J. Suárez de Lezo, and M. Pan, “A new classification of coronary bifurcation lesions,” Revista Espanola de Cardiologia, vol. 59, no. 2, p. 183, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Vassilev, R. Gil, and K. Milewski, “Bifurcation Optimisation Stent System (BiOSS Lim) with sirolimus elution: results from porcine coronary artery model,” EuroIntervention, vol. 7, no. 5, pp. 614–620, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Onuma and P. W. Serruys, “Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?” Circulation, vol. 123, no. 7, pp. 779–797, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Ruzsa, M. van der Linden, N. M. Van Mieghem et al., “Culotte stenting with bioabsorbable everolimus-eluting stents,” International Journal of Cardiology, vol. 168, no. 2, pp. e35–e37, 2013. View at Publisher · View at Google Scholar
  8. D. Capodanno, T. Gori, H. Nef et al., “Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry,” EuroIntervention, vol. 10, no. 10, pp. 1144–1153, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Lipinski, R. O. Escarcega, N. C. Baker et al., “Scaffold thrombosis after percutaneous coronary intervention with ABSORB bioresorbable vascular scaffold: a systematic review and meta-analysis,” JACC: Cardiovascular Interventions, vol. 9, pp. 12–24, 2016. View at Google Scholar
  10. G. W. Stone, R. Gao, T. Kimura et al., “1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis,” The Lancet, 2016. View at Publisher · View at Google Scholar